CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Significant Decrease in Short Interest

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) saw a large drop in short interest in May. As of May 31st, there was short interest totalling 22,100 shares, a drop of 30.9% from the May 15th total of 32,000 shares. Based on an average daily volume of 33,000 shares, the short-interest ratio is presently 0.7 days.

CERo Therapeutics Trading Down 24.7%

Shares of NASDAQ:CEROW opened at $0.03 on Thursday. CERo Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.06. The company has a fifty day moving average of $0.01 and a 200-day moving average of $0.01.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.